期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分化型甲状腺癌靶向治疗药物研究新进展

New progress in targeted therapy of differentiated thyroid cancer
原文传递
导出
摘要 分化型甲状腺癌作为常见内分泌系统恶性肿瘤疾病的一种,可取得良好预后效果,但对于少数难治性(放射性核元素抵抗或出现局部转移、浸润等)患者通过传统治疗方式无法取得理想效果,近年来,随着临床的深入研究及医疗水平不断发展,从分子层面出发,对于难治性甲状腺癌靶标靶向治疗成为前沿领域,并获得一些新的肿瘤治疗分子靶点,如索拉菲尼、乐伐替尼等药物已成为难治性分化型甲状腺癌临床实验及应用的靶向药物,为晚期甲状腺癌的治疗扩展了新道路.
作者 徐世新 王辉 张培钢
机构地区 天津市公安医院
出处 《首都食品与医药》 2021年第12期10-11,共2页 Capital Food Medicine
关键词 分化型甲状腺癌 靶向治疗 靶向药物
分类号 R736.1 [医药卫生—肿瘤]
  • 相关文献

参考文献9

二级参考文献69

  • 1高再荣,安锐,张永学,Hans J．Biersack.核素靶向治疗在转移性甲状腺髓样癌治疗中的价值[J].中华肿瘤杂志,2006,28(8):621-624. 被引量：8
  • 2Itaru Omoto,Masataka Matsumoto,Hiroshi Okumura,Yasuto Uchikado,Tetsuro Setoyama,Yoshiaki Kita,Tetsuhiro Owaki,Yuko Kijima,Hiroyuki Shinchi,Sumiya Ishigami,Shinichi Ueno,Shoji Natsugoe.Expression of vascular endothelial growth factor?C and vascular endothelialgrowth factor receptor?3 in esophageal squamous cell carcinoma[J]. Oncology Letters . 2014 (4)
  • 3Teresa Di Desidero,Anna Fioravanti,Paola Orlandi,Bastianina Canu,Riccardo Giannini,Nicla Borrelli,Shan Man,Ping Xu,Gabriella Fontanini,Fulvio Basolo,Robert S. Kerbel,Giulio Francia,Romano Danesi,Guido Bocci.Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1[J].The Journal of Clinical Endocrinology & Metabolism.2013(9)
  • 4E. E. W. Cohen,M. Tortorici,S. Kim,A. Ingrosso,Y. K. Pithavala,P. Bycott.A Phase II trial of axitinib in patients with various histologic subtypes of advanced thyroid cancer: long-term outcomes and pharmacokinetic/pharmacodynamic analyses[J]. Cancer Chemotherapy and Pharmacology . 2014 (6)
  • 5Osamu Tohyama,Junji Matsui,Kotaro Kodama,Naoko Hata-Sugi,Takayuki Kimura,Kiyoshi Okamoto,Yukinori Minoshima,Masao Iwata,Yasuhiro Funahashi,Giovanni Tallini.Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models[J]. Journal of Thyroid Research . 2014
  • 6Kriti Mittal,John Ebos,Brian Rini.Angiogenesis and the Tumor Microenvironment: VEGF and Beyond[J]. Seminars in Oncology . 2014
  • 7Marcia S Brose,Christopher M Nutting,Barbara Jarzab,Rossella Elisei,Salvatore Siena,Lars Bastholt,Christelle de la Fouchardiere,Furio Pacini,Ralf Paschke,Young Kee Shong,Steven I Sherman,Johannes W A Smit,John Chung,Christian Kappeler,Carol Pe?a,István Molnár,Martin J Schlumberger.Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial[J]. The Lancet . 2014
  • 8Jirka Grosse,Elisabeth Warnke,Markus Wehland,Jessica Pietsch,Fabian Pohl,Petra Wise,Nils E. Magnusson,Christoph Eilles,Daniela Grimm.Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells[J]. Apoptosis . 2014 (3)
  • 9Luca Mologni,Sara Redaelli,Andrea Morandi,Ivan Plaza-Menacho,Carlo Gambacorti-Passerini.Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase[J]. Molecular and Cellular Endocrinology . 2013 (1-2)
  • 10Keith C Bible,Vera J Suman,Julian R Molina,Robert C Smallridge,William J Maples,Michael E Menefee,Joseph Rubin,Kostandinos Sideras,John C Morris,Bryan McIver,Jill K Burton,Kevin P Webster,Carolyn Bieber,Anne M Traynor,Patrick J Flynn,Boon Cher Goh,Hui Tang,Susan Percy Ivy,Charles Erlichman.Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study[J]. Lancet Oncology . 2010 (10)

共引文献59

首都食品与医药
2021年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部